Mucopolysachharidosis-II: A Rare Case Report

Show other versions (1)

Mucopolysaccharidosis belongs to a group of metabolic disorders caused by absence or defective activity of lysosomal enzymes. Mucopolysaccharides are major components of intercellular connective tissue and defect in their metabolism leads to an accumulation of incompletely degraded mucopolysacchari...

Full description

Bibliographic Details
Published in:	Nepal Journal of Dermatology, Venereology & Leprology
Main Authors:	Kalgi Baxi, Ashish Jagati, Pooja Agarwal
Format:	Article
Language:	English
Published:	Society of Dermatologists, Venereologists and Leprologists of Nepal (SODVELON) 2020-10-01
Subjects:	Glycosaminoglycans Iduronic Acid Lysosomes Mucopolysaccharidosis II
Online Access:	https://nepjol.info/index.php/NJDVL/article/view/25996

Similar Items

Mucopolysachharidosis-II: A Rare Case Report
by: Kalgi Baxi, et al.
Published: (2020-10-01)

Enhanced osteoblastic differentiation of parietal bone in a novel murine model of mucopolysaccharidosis type II
by: Narutoshi Yamazaki, et al.
Published: (2023-12-01)

A study of the relationship between clinical phenotypes and plasma iduronate-2-sulfatase enzyme activities in Hunter syndrome patients
by: Ok Jeong Lee, et al.
Published: (2012-03-01)

Predicción computacional de la estructura terciaria de la iduronato 2-sulfato sulfatasa humana
by: Homero Sáenz, et al.
Published: (2007-03-01)

Hunter Syndrome: Clinical Case of Early Diagnostics
by: Natalya N. Martynovich, et al.
Published: (2020-11-01)

Rapid genotyping of inversion variants in Mucopolysaccharidosis type II using long-range PCR: A case report
by: Yusuke Hattori, et al.
Published: (2024-12-01)

Molecular basis of mucopolysaccharidosis type II (Hunter syndrome): first review and classification of published IDS gene variants
by: Alessandra Zanetti, et al.
Published: (2024-12-01)

Twenty years of Colombian experience with enzymatic screening in patients with features of mucopolysaccharidosis
by: Alfredo Uribe‐Ardila, et al.
Published: (2022-09-01)

Results of 14-year-long Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II: Clinical Case
by: Natalia V. Zhurkova, et al.
Published: (2023-01-01)

Frequency of iduronate-2-sulfatase gene variants detected in newborn screening for mucopolysaccharidosis type II in Japan
by: Yusuke Hattori, et al.
Published: (2023-12-01)

A New Mutation in IDS Gene Causing Hunter Syndrome: A Case Report
by: Caio Perez Gomes, et al.
Published: (2020-03-01)

Glaucoma in mucopolysaccharidoses
by: Weijing Kong, et al.
Published: (2021-07-01)

Chondroitin sulfate disaccharide is a specific and sensitive biomarker for mucopolysaccharidosis type IVA
by: Sharon J. Chin, et al.
Published: (2020-09-01)

Mucopolysaccharidosis type II (Hunter syndrome) in a boy from the Republic of Serbia: A case report
by: Tubić-Vukajlović Jovana M., et al.
Published: (2023-01-01)

Levels of glycosaminoglycans in the cerebrospinal fluid of healthy young adults, surrogate-normal children, and Hunter syndrome patients with and without cognitive impairment
by: Christian J. Hendriksz, et al.
Published: (2015-12-01)

Transferrin receptor-targeting property of pabinafusp alfa facilitates its uptake by various types of human brain-derived cells in vitro
by: Tomoki Fukatsu, et al.
Published: (2023-07-01)

Clinical Profile Among Brazilian Mucopolysaccharidosis type II Patients: Subgroup Analysis from the Hunter Outcome Survey
by: Dafne D G Horovitz, et al.
Published: (2023-09-01)

Efficacy and safety of a biosimilar laronidase versus the reference laronidase in patients with mucopolysaccharidosis type I
by: Ali Rabbani, et al.
Published: (2025-08-01)

Clinical, Biochemical and Molecular Characteristics of Fifteen Patients with Mucopolysaccharidosis Type II in Western Turkey
by: Havva Yazıcı, et al.
Published: (2018-03-01)

Avaliação prospectiva de 11 pacientes brasileiros com mucopolissacaridose II Prospective study of 11 Brazilian patients with mucopolysaccharidosis II
by: Louise L. C. Pinto, et al.
Published: (2006-08-01)

A Systematic Literature Review on the Global Status of Newborn Screening for Mucopolysaccharidosis II
by: Olulade Ayodele, et al.
Published: (2024-10-01)

Diagnosis and Management of Mucopolysaccharidosis Type II (Hunter Syndrome) in Poland
by: Zbigniew Żuber, et al.
Published: (2023-06-01)

The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis
by: Alexis David, et al.
Published: (2023-03-01)

Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapy
by: Stuart Ellison, et al.
Published: (2023-12-01)

Novel Phenotypic Insights into the <i>IDS</i> c.817C>T Variant in Mucopolysaccharidosis Type II from Newborn Screening Cohorts
by: Éliane Beauregard-Lacroix, et al.
Published: (2025-08-01)

Case report: a rare case of Hunter syndrome (type II mucopolysaccharidosis) in a girl
by: A. N. Semyachkina, et al.
Published: (2019-05-01)

Atypical presentation of mucopolysaccharidosis type IVA
by: Eric T. Rush
Published: (2016-09-01)

EFFICACY AND SAFETY OF ENZYME REPLACEMENT THERAPY IN CHILDREN WITH MUCOPOLYSACCHARIDOSIS TYPE I, II, AND VI: A SINGLE-CENTER COHORT STUDY
by: Liliia A. Osipova, et al.
Published: (2018-04-01)

Mucopolysaccharidosis type II: Enzyme Replacement Therapy Efficiency
by: Nato D. Vashakmadze, et al.
Published: (2020-02-01)

The diagnosis and management of mucopolysaccharidosis type II
by: Shao-Jia Mao, et al.
Published: (2024-10-01)

Initiation of fluoxetine in a pediatric patient with Mucopolysaccharidosis IIIA: Early observations
by: Lindsay Torrice, et al.
Published: (2024-09-01)

Non-Neuropathic Form of Mucopolysaccharidosis Type II: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2021-03-01)

A second reported malignancy in a patient with Morquio syndrome
by: Ameer Hamza, et al.
Published: (2017-06-01)

Evaluation of Two Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis Type II
by: Zackary M. Herbst, et al.
Published: (2022-01-01)

Hurler Syndrome: a Biochemically Confirmed Case in Dominican Republic
by: Kimberly Baez-Nicodemo, et al.
Published: (2023-03-01)

Identification of 17 novel mutations in 40 Argentinean unrelated families with mucopolysaccharidosis type II (Hunter syndrome)
by: H. Amartino, et al.
Published: (2014-01-01)

Types and Genetic Evaluation of Lysosomal Storage Diseases in Kurdistan Region
by: Lana Ahmed Mohammed
Published: (2025-06-01)

Proteomic Analysis of Mucopolysaccharidosis IIIB Mouse Brain
by: Valeria De Pasquale, et al.
Published: (2020-02-01)

Home treatment of type VI mucopolysaccharidosis (Maroteaux‐Lamy syndrome) an alternative at this time of COVID‐19 pandemic: A case in Peru
by: Jenny Lucy Cortez Miranda, et al.
Published: (2020-12-01)

Mucopolysaccharidosis Type 1 among Children—Neuroradiological Perspective Based on Single Centre Experience and Literature Review
by: Magdalena Machnikowska-Sokołowska, et al.
Published: (2023-01-01)